CHRISTELLE NIMBA: Open Payments
NPI 1841955663 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 27 payments from 7 companies in 2025. Trend: 2023 $333 · 2024 $1,252 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $294 |
| ABBVIE INC. | 4 | $110 |
| Lilly USA, LLC | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Astellas Pharma US Inc | 1 | $29 |
| PFIZER INC. | 1 | $19 |
Products named: Ozempic, JARDIANCE, QULIPTA, Rybelsus, XIFAXAN, MOUNJARO, Veozah, VRAYLAR.
Industry payments across CT — which companies pay providers there.
